Japan Active Implantable Medical Devices Market Size & Outlook, 2025-2033
Japan Active Implantable Medical Devices Market Insights
- Reed Intelligence analysis indicates that the Japan Active Implantable Medical Devices Market size, valued at USD 639.47 Million in 2024, is expected to expand to USD 1241.88 Million by 2033.
- The Japan market is forecasted to expand at a CAGR of 7.63% spanning 2025–2033.
- Implantable Cardioverter Defibrillators held the leading position among By Product segments in 2024, based on market size.
- Implantable Heart Monitors/Insertable Loop Recorders is projected to post the fastest growth rate, sustaining its position as the most attractive By Product segment during the forecast horizon.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, Japan held 2.48% of the global Active Implantable Medical Devices Market size.
- By 2033, United States is anticipated to capture the largest share of the global Active Implantable Medical Devices Market.
- In Asia Pacific, China is expected to lead the regional Active Implantable Medical Devices Market size by 2033.
- Japan will remain the fastest-growing market in Asia Pacific, reaching USD 1239.44 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 639.47 Million |
| Market Size In 2033 | USD 1241.88 Million |
| Largest segment | Implantable Cardioverter Defibrillators |
| Units | Revenue in USD Million |
| CAGR | 7.63% (2025-2033) |
| Segmnetation Covered | |
| By Product |
|
| By End-User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Japan Active Implantable Medical Devices Market By Product 2025-2033 (USD Million)
| By Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Implantable Cardioverter Defibrillators | XX.x | XX.x | XX.x | 196.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Implantable Cardiac Pacemakers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ventricular Assist Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Implantable Heart Monitors/Insertable Loop Recorders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Neurostimulators | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Implantable Hearing Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Japan Active Implantable Medical Devices Market By End-User 2025-2033 (USD Million)
| By End-User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 299.6 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgery Center | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
